反応式
[CH3:1][CH2:2][CH2:3][CH2:4][C:5]1[N:9]([CH2:10][C:11]2[CH:12]=[CH:13][C:14]([C:17]([OH:19])=[O:18])=[CH:15][CH:16]=2)[C:8](/[CH:20]=[C:21](/[C:28]([OH:30])=[O:29])\[CH2:22][C:23]2[S:27][CH:26]=[CH:25][CH:24]=2)=[CH:7][N:6]=1.[CH3:31][S:32]([OH:35])(=[O:34])=[O:33]>C(O)(C)C>[CH3:1][CH2:2][CH2:3][CH2:4][C:5]1[N:9]([CH2:10][C:11]2[CH:12]=[CH:13][C:14]([C:17]([OH:19])=[O:18])=[CH:15][CH:16]=2)[C:8](/[CH:20]=[C:21](/[C:28]([OH:30])=[O:29])\[CH2:22][C:23]2[S:27][CH:26]=[CH:25][CH:24]=2)=[CH:7][N:6]=1.[CH3:31][S:32]([OH:35])(=[O:34])=[O:33]参加物
反応条件
- 温度
- 8 °C
実験手順
As per the process described and exemplified in the U.S. Pat. No. 5,185,351 (herein after referred to as the '351 patent), eprosartan free base (obtained as per the processes described in example I of the '351 patent) is suspended in isopropyl alcohol under stirring at about 8° C., methanesulfonic acid is added rapidly to the stirred suspension, the mass cooled to 3° C. and the precipitated solid collected to give crude eprosartan mesylate. The crude eprosartan mesylate is further purified by dissolving crude eprosartan mesylate in acetic acid at 80° C., filtered through a hyflow bed at 80° C., the solution cooled slowly to 25° C. followed by stirring and then the precipitated solid is collected by adding ethyl acetate as an anti-solvent to give eprosartan mesylate.
後処理
- customobtained as per the processes
- temperaturethe mass cooled to 3° C.
- customthe precipitated solid collected
- customto give crude eprosartan mesylate
- customThe crude eprosartan mesylate is further purified
- dissolutionby dissolving crude eprosartan mesylate in acetic acid at 80° C.
- filtrationfiltered through a hyflow bed at 80° C.
- temperaturethe solution cooled slowly to 25° C.
- stirringby stirring
- customthe precipitated solid is collected
- additionby adding ethyl acetate as an anti-solvent
出典と根拠
- ORDレコード
- ord-aaf8478e97c44019b00c510f86452a37
- 出典データセット
- uspto-grants-2013_01
- 特許番号
- US08361507B2
関連ノート
読み込み中…